查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2138650

生物玻璃市場報告：趨勢、預測和競爭分析（至2035年）

Bioglass Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物玻璃市場

受牙科、整形外科和植入生物材料市場機會的推動，全球生物玻璃市場前景廣闊。預計到2035年，全球生物玻璃市場規模將從2027年的7.51億美元成長至13.4億美元，2027年至2035年的複合年成長率（CAGR）為4.3%。推動該市場成長的關鍵因素包括：醫療應用領域對生物相容性材料的需求不斷成長、醫療產業的擴張和老化，以及人們對先進生物材料和永續性的日益關注。

  • 根據 Lucintel 的預測，按產品類型分類，傳統矽酸鹽玻璃在預測期內預計將呈現最高的成長率，因為它具有良好的生物相容性，並在臨床環境中廣泛應用。
  • 從應用領域來看，整形外科領域預計將在整個預測期內呈現最高的成長率，這主要得益於骨骼疾病盛行率的上升和整形外科手術數量的增加。
  • 從區域來看，由於北美擁有先進的醫療服務和廣泛的整形外科手術資源，預計北美在預測期內將呈現最高的成長率。

生物玻璃市場的新趨勢

預計2025年至2027年間，生物玻璃在牙科和整形外科領域的專業應用將有所下降，而其在再生醫學和精密製造領域的應用預計將會增加。臨床試驗投入的增加和政府監管的日益嚴格將促進生物玻璃的市場成長。醫療保健機構越來越關注所用材料的永續性。他們尋求能夠加速癒合過程，同時減少額外侵入性手術和廢棄物的材料。

  • 永續性：製造商已經在致力於開發更永續的生物玻璃生產方法。相關研究也支持這一方向，這些研究探討了使用回收材料取代新型材料的可能性。在醫療保健系統中，永續性很可能在未來三到五年內成為供應商評估的新標準。
  • 數位製造：近年來，研究重點在於開發易於成型為特定形狀的生物玻璃。許多研究也分析了具有均勻孔隙分佈的生物玻璃的開發。生物玻璃可以根據患者的骨缺損形狀進行定製成型。
  • 智慧材料：目前的研究表明，人們正致力於將多種主動控制系統整合到生物玻璃中，以調節其溶解和生物反應。在專用治療材料研發成功之前，智慧材料很可能成為生物玻璃市場的主要驅動力。預計製造商最初將專注於將生物玻璃與活性成分釋放系統結合。
  • 臨床領域專長：45S5 和 S53P4 在一般骨缺損填補的應用正迅速擴展到牙科、脊椎護理和慢性創傷護理等領域。一項發表於 2025 年的研究重點在於離子釋放與患者癒合之間的關聯。
  • 供應鏈區域多元化：鑑於2025年醫療材料供應鏈屢遭中斷，買家目前正尋求在歐洲、北美和亞洲尋找替代貨源。然而，由於許多此類材料需要進行廣泛的生物相容性測試，新貨源的認證仍需時日。儘管如此，跨區域生產將有助於在2030年之前持續供應並促進採購談判。

與供需關係、臨床可行的解決方案和加工技術以及保險報銷相比，生物玻璃原料的創新在生物玻璃市場成長中的作用相對較小。整合供應鏈管理和結果檢驗的供應商應能擴大其在牙科和整形外科醫療設備領域的市場佔有率。監管將減緩創新，但永續性和數位化製造將在2030年前改善市場經濟狀況。隨著醫院採購標準的日益成熟，我們有望看到生物玻璃在專業應用領域的拓展。

生物玻璃市場的最新趨勢

到2025年，生物玻璃市場將進一步從牙科和創傷護理轉向再生醫學和緩釋系統。 2026年的成長主要由投資驅動，而2027年，產能和臨床計畫的投資將成為成長的主要動力。根據Lucintel預測，該市場將持續成長，但生產和監管方面的限制可能會使任何重大變革都局限於先導計畫。

  • 擴大產能：為解決醫用級生物玻璃的供應瓶頸，製造商計劃於2025年6月提升其熔煉和加工能力。這將使植入和組織工程領域的客戶能夠克服逐批供貨的限制。
  • 監管批准：截至2025年9月，生物活性玻璃產品已獲得監管部門批准，可用於骨骼和牙齒修復。每項批准都提高了可靠性，並縮短了醫院系統的採購前置作業時間。
  • 策略合作：2026年3月，一所大學與一家生物材料企業合作就用於3D列印支架的生物材料達成最終合作協議。初期，雙方將在生物材料的銷售方面競爭，但這種合作模式將確保穩定的收入來源。
  • 技術創新：供應商於2026年1月推出了一系列新型生物玻璃產品，其粒徑小於100微米，可提供注射型和積層製造（3D列印）兩種形式。這種新型生物玻璃將透過提高可製造性和減少缺陷，拓展生物玻璃在微創外科手術技術中的應用範圍。
  • 臨床投資：2025年，多個專注於生物活性分子臨床應用和軟組織再生的調查計畫獲得了資助。這將推動這些產品在未來3-5年內價格上漲。

成長並非取決於品牌知名度的提升，而是取決於生產流程的可複製性和保險報銷系統。牙科領域將是最初的收入來源，而整形外科領域則蘊藏著更大的成長機會。專注於骨科領域將有助於在醫院領域獲得合約。值得信賴的、提供經臨床驗證的無菌粉末和可生物分解材料的供應商將贏得合約。輸送系統整合商和契約製造商將獲得優先考慮。買家將以更低的價格購買通用粉末。

目錄

第1章執行摘要

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章：全球生物玻璃市場：按類型分類

  • 吸引力分析：按類型
  • 傳統矽酸鹽玻璃
  • 玻璃陶瓷
  • 硼酸鹽玻璃

第5章：全球生物玻璃市場：依應用領域分類

  • 吸引力分析：依目的
  • 牙科
  • 整形外科
  • 接枝到生物材料中
  • 其他

第6章 區域分析

第7章：北美生物玻璃市場

  • 北美生物玻璃市場：按類型分類
  • 北美生物玻璃市場：按應用領域分類
  • 美國生物玻璃市場
  • 墨西哥生物玻璃市場
  • 加拿大生物玻璃市場

第8章：歐洲生物玻璃市場

  • 歐洲生物玻璃市場：按類型分類
  • 歐洲生物玻璃市場：按應用領域分類
  • 德國生物玻璃市場
  • 法國生物玻璃市場
  • 西班牙生物玻璃市場
  • 義大利生物玻璃市場
  • 英國生物玻璃市場

第9章：亞太地區生物玻璃市場

  • 亞太地區生物玻璃市場：按類型分類
  • 亞太地區生物玻璃市場：依應用領域分類
  • 日本生物玻璃市場
  • 印度生物玻璃市場
  • 中國生物玻璃市場
  • 韓國生物玻璃市場
  • 印尼生物玻璃市場

第10章：世界其他地區的生物玻璃市場

  • 其他地區生物玻璃市場：按類型分類
  • 其他地區生物玻璃市場：依應用領域分類
  • 中東生物玻璃市場
  • 南美洲生物玻璃市場
  • 非洲生物玻璃市場

第11章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球生物玻璃市場
  • 戰略分析

第13章：價值鏈中關鍵企業的公司概況

  • Competitive Analysis
  • Arthrex
  • Biomet
  • NORAKER
  • SCHOTT
  • Stryker
  • BonAlive Biomaterials
  • British Glass Manufacturers'Confederation

第14章附錄

Bioglass Market

The future of the global bioglass market looks promising with opportunities in the dental, orthopedic, and grafting biomaterial markets. The global bioglass market is expected to reach an estimated $1,340 million by 2035 from $751 million in 2027 with a CAGR of 4.3% from 2027 to 2035. The major drivers for this market are the rising demand for biocompatible materials in medical applications, the growing healthcare sector & aging population, and the increasing focus on advanced biomaterials & sustainability.

  • Lucintel forecasts that, within the type category, conventional silicate glass is expected to witness the highest growth over the forecast period due to result of well documented biocompatibility and extensive clinical use.
  • Within the application category, orthopedic is expected to witness the highest growth over the forecast period due to growing prevalence of bone disorders and orthopedic procedures.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period due to growing availability of advanced healthcare and orthopedic surgery practice.

Emerging Trends in Bioglass Market

Between 2025 and 2027, specialist dental and orthopedic applications for bioglass will decrease, while applications for regenerative medicine and precision manufacturing will increase. Clinical investments and more stringent government reviews will help create markets for bioglass. Healthcare providers are more interested in the sustainability of the materials they use. They want materials that will help in the healing process while reducing additional, invasive surgeries and waste.

  • Sustainability: Manufacturers are already working to develop more sustainable ways to produce bioglass. This is proven by research that analyzes using recycled materials as feedstock instead of using new materials. Healthcare systems are likely to make sustainability a new criterion for evaluating their suppliers in the next three to five years.
  • Digital Manufacturing: Research in the last few years was focused on developing bioglass that can be easily molded to fit specific shapes. Many studies in the last few years also analyzed developing bioglass with an even pore distribution. Bioglass can be molded specifically to match the shape of a patient's bone defect.
  • Smart Materials: Current research is merging bioglass with several active control systems for the dissolution and biological response. Smart materials will dominate the bioglass market until dedicated therapeutic sources are developed. Manufacturers will initially focus on merging bioglass with systems to release an active substance.
  • Clinical Specialization: Applications of 45S5 and S53P4 for general bone filling are also rapidly expanding into dental, spinal and chronic wound care. Research published in 2025 focused on comparing the release of ions to the healing of the patient.
  • Regional Supply Diversification: After several disruptions to medical-material supply chains in 2025, buyers are now looking for alternative supplies in Europe, North America, and Asia, but qualifying new sources remains a lengthy process as many of these materials require extensive biocompatibility testing. Multi-regional manufacturing will, however, improve the continual supply and negotiation potential of supplies through 2030.

Innovation in the raw materials used for bioglass will play a smaller role in the growth of the bioglass market relative to supply/demand, clinically viable solutions and processing, and reimbursement. Suppliers that integrate control of supply with verification of results should gain market share for both dental and orthopedic devices. Regulation will slow innovation, but sustainability and digital manufacturing will improve the economics of the market through 2030. Once procurement standards mature across hospitals, we should start to see specialty applications.

Recent Developments in the Bioglass Market

By 2025, the bioglass market will shift further from dental and wound care into regenerative medicine and controlled-release systems. While growth was investment-driven in 2026, investments in capacity and clinical programs will drive growth in 2027. According to Lucintel, the market is predicted to grow; however, the limits of manufacturing and regulation will still limit market disruptions to pilot projects.

  • Capacity Building: In June 2025, manufacturers will add melting and processing capacity to address a constraint in the supply of medical grade bioglass. This will enable implant and tissue engineering customers to overcome batch constraints.
  • Regulatory Approvals: By September 2025, bioactive glass products received regulatory approval for use in bone and dental repair. Each approval increases confidence and reduces lead time for procurement by hospital systems.
  • Strategic Partnerships: Corporate partnerships between universities and biomaterials companies for 3D-printed scaffold biomaterials were finalized in March 2026. Initially these partnerships will be competing for sales of biomaterials, however these arrangements will ensure a consistent revenue stream.
  • Technology Innovations: Suppliers introduced a new line of bioglass that can be used in an injectable and additive manufacturing formats with particles of less than 100 micrometers (January 2026). The new bioglass improves manufacturing, and reduces defects, enabling broader use of bioglass in minimally invasive surgical techniques.
  • Clinical Investment: In 2025, several research programs focused on clinical delivery of bioactive molecules and regeneration of soft tissues received funding. This will support price inflation of these products over the next 3-5 years.

Growth will be driven less by awareness. Instead, it will be dependent on repeatable processes for manufacturing and reimbursement. Dental will be the initial revenue stream, whereas orthopedics will be the larger growth opportunity. Focus will bring contracts in the hospital sphere. Reliable suppliers of sterile powders and degradable materials with documented clinical performance will win the contracts. Delivery systems integrators and contract manufacturing providers will be preferred. Buyers will pay less for commodity powders.

Strategic Growth Opportunities in the Bioglass Market

From 2024 to 2026, the market for bioglass will shift from specialty bone repair to broader applications in regenerative medicine and advanced dentistry. As hospitals aim for shorter recovery times, manufacturers will need to meet demands for greater traceability and sustainability of their materials. Lucintel identifies market potential for biological performance combined with manufacturing that is both scalable and clinically validated.

  • Dental Regeneration: Investment in injectable and putty bioglass can serve treatments for periodontal defects, implant coatings, and hypersensitivity. January 2025 saw the public dental market for implants reach over $4 billion. In the next 3 to 5 years, dentists will purchase more products that reduce time spent in the chair and support precipitation.
  • Orthopedic Trauma: High porosity scaffolds and bioglass polymer composites can be used for spinal fusion, fracture, and revision surgery. An estimated 1 million hip and knee replacement procedures are done in the US each year. Growing older and the demand for synthetic graft substitutes will encourage hospitals to move beyond traditional bone substitutes.
  • Premium Bioactive Formulations: Bioglasses with strontium, copper, and zinc will be more expensive where their antimicrobial properties and faster healing are desired. In February 2025, some published research showed that certain bioactive glasses can release ions for more than four weeks. In the next 3 to 5 years, special formulations of these will likely lead to higher profits as clinicians pay for real performance, not generic powders.
  • Local bioglass production and partnerships with regulatory groups may offer opportunities for expanding into India, Southeast Asia and Latin America. By 2030 medical devices are projected to be a $50 billion industry in India. Local manufacturing of dental and orthopedic devices will aid in lowering the cost of imports.
  • Digital Customization: 3D printed bioglass scaffolds with pore structures specifically designed to match the surgical plans and the geometry of the defect can be manufactured. In May 2025, results of additive manufacturing research demonstrated designs with porosities in the range of 60%-100%. This technology will help shift the emphasis of the business to the development of customized implants and design software coupled with additive manufacturing.

Clinically approved products will create a demand for narrowly specific materials over broad claims. To offer supply chain services, regulatory compliance, reliable Ion release, and industrial scale will be necessary. Local production combined with digital design will provide advantages over competitors and will help offset price competition for basic bioglass powder.

Bioglass Market Drivers and Challenges

Bioglass has a growing market driven by technology, demand for healthcare, the economy, sustainability, and the changing regulations. The uses in bone and dental restoration, regeneration, wound care, and coatings broaden its market potential. There are high development costs, the need for clinical validation, substantiation for market access, and unpredictable reimbursement which limit growth. Lucintel considers innovation along with the expansion of both technology and biomaterials as major contributors. The success of companies in the marketplace in the next few years will depend on their ability to convert innovative laboratory advancements into practical and affordable products which receive acceptance in the clinical community.

The Major Driving Forces of The bioglass market Are: -

  • Increasing Demand for Regenerative Healthcare: The rising demands for orthopedic, dental, and wound-care treatments have resulted in an increased interest in bioactive materials that aid tissue integration and healing. Over 800 million people reached the age of 65 in the year 2025 and the demand for bone repair along with the other aging population related challenges becomes a greater concern and will act as a market driver over the next three to five years.
  • Technology-related Improvements: Better compositions of glass, the use of nanoparticles, and ion-release combined with 3D printing and other technologies, improve bioglass. 2025 was also a year of great activity in the additional suiting sector of biomedical manufacturing as customizations continued (March 2025). Better implants and materials made in bioglass along with shorter and controlled ion-release would also be market drivers as the processes become better controlled.
  • Regulatory and Clinical Support: Relatively mature biomaterial standards and the strengthening of clinical evidence are building confidence in healthcare professionals and manufacturers. 2025 saw the full implementation of the European Union's Medical Device Regulation. This has strengthened the requirements for the safety of the design, clinical evaluation, and market surveillance. The next three to five years will see a preference for a strong compliance system among suppliers with validated products. This will result in a decrease in the uncertainty associated with the adoption of bioglass.
  • Sustainability and Material Innovation: Bioglass can support designs of biomedical products with a lower waste footprint, waste-efficient coatings, and the replacement of some petroleum-based and/or poorly degradable materials. The European Union's packaging regulation was implemented in February 2025. This will create additional market pressure for the widespread use of more recyclable and waste-efficient materials. As hospitals, manufacturers, and investors assess a product's performance in the context of safer chemistry, lower waste, and longer product lifecycles, this driver of sustainability will influence both the design and the materials used in biomedical devices.
  • Manufacturing Efficiency and Application Expansion: Recent advancements in powder production, melt processing, and sol-gel synthesis and quality control have empowered companies to produce more consistent products. In 2025, healthcare manufacturers continued a trend of increasing investments in automation to ensure continuous traceability and a lower variability in the manufacturing process (June 2025). This trend will shape the market by allowing automation to decrease the cost of each unit produced while increasing the overall volume of units produced and allowing bioglass to be implemented in new applications beyond implants for use in coatings, dental products, drug delivery and wound-care.

This Market encounters the following challenges:

  • High Development and Validation Costs: Due to the extensive laboratory work, biocompatibility assessments, clinical studies and trials, and the subsequent documentation to regulatory agencies, medical device companies report longer evidence generation times to market by 2025 due to regulatory emphases on clinical data and post-market monitoring (April 2025). This trend will persist for the next three to five years and favor large, well-funded companies at the expense of smaller companies creating more innovative products.
  • Manufacturing Complexity and Quality Consistency: Variations in manufacturing, such as part size, porosity, and surface modification, can affect the performance of biomaterials and reduce the desired outcomes and properties of mechanical performance. By 2025, manufacturers began to set more stringent process control criteria for advanced biomaterials to ensure the consistency of each batch (August 2025). This will impact the Market because turning a laboratory research product into a reliable commercial product requires complex instrumentation, dedicated staff, and high quality control,
  • Reimbursement and Cost Sensitivity: Healthcare facilities and patients will not consider the adoption of bioglass if the policies do not consider the long-term benefits of bioglass and cheaper alternatives exist. Cost-containment measures continued in 2025, especially for elective procedures and non-essential technologies (October 2025). For the next three to five years, unless the suppliers can demonstrate better outcomes with a reduction in the costs for a healthcare provider, slow adoption due to inadequate reimbursement will persist.

The market for bioglass will continue to grow because of the increasing need for regenerative medicine, dental treatment, wound care, and personalized implants. There are many opportunities to improve technology and manufacturing to make bioglass products better and more diverse. Sustainability also makes the market more appealing to customers. However, there are several challenges including the need for more clinical validation and approval by regulatory agencies. Ending uncertainty about product consistency will help make reimbursements easier. Companies that can provide strong evidence, low-cost manufacturing, and custom-made innovations will be best positioned for growth. The market will continue to grow when researchers are able to make scientific discoveries that provide reliable and low-cost healthcare treatments that are more widely reimbursed.

List of Bioglass Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies bioglass market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioglass market companies profiled in this report include-

  • Arthrex
  • Biomet
  • NORAKER
  • SCHOTT
  • Stryker
  • BonAlive Biomaterials
  • British Glass Manufacturers' Confederation

Bioglass Market by Segment

The study includes a forecast for the global bioglass market by type, application, and region.

Bioglass Market by Type [Value ($M) from 2019 to 2035]:

  • Conventional Silicate Glass
  • Glass Ceramics
  • Borate-based Glass

Bioglass Market by Application [Value ($M) from 2019 to 2035]:

  • Dental
  • Orthopedic
  • Grafting Biomaterials
  • Others

Bioglass Market by Region [Value ($M) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Bioglass Market

The bioglass market is approaching broader, regulated, medical and dental applications with the support of public funding and emerging manufacturing options for biomaterials. With these developments, Lucintel says market expansion is likely. There are, however, some limitations on market entry that are tied to adequate reimbursement and clinical case validation.

  • United States: The FDA's Quality Management System Regulation is anticipated to come into effect in February 2026. Before that, the FDA has been providing some support for the 510(k) clearances of bioactive glass bone-grafts and dental applications. Once this deadline is met by manufacturers, they will be motivated to invest in validated production, and supporting documentation and controls for their suppliers. This will be accomplished over the next three to five years.
  • China: By 2025, the Chinese 14th Five-Year Plan will conclude. During this period, biomaterials and high-performance medical materials have been considered strategic or priority areas. The Chinese government is also continuing to extend centralized medical-device procurement and registration systems. By 2025, when this plan is expected to conclude, bioglass capacity in China is expected to increase. This will happen through funding of research and the development of local supply chains.
  • Germany: The German market remains subject to the European Union's Medical Device Regulation. The deadline for the amended transition will be December 2027. German specialty materials producers and research organizations are focusing on clinical evidence and manufacturing that meets the required standards. This 2027 deadline will likely impact bioglass product market access especially as the evidence and quality requirements will increase.
  • India: With India's ongoing National Medical Devices Policy and the Department of Pharmaceuticals' production-linked incentives, there is a continued push for domestic manufacturing, and the Indian government has set targets for reducing the medical device import dependency. The policy framework estimates a domestic medical device market size of approx. $11 billion for 2023 (February 2024). The emphasis on manufacturing will facilitate the commercialization of bioglass through local manufacturing of medical device implants and technology partnerships.
  • Japan: The Pharmaceuticals and Medical Devices Agency of Japan has adopted a risk-based approach for approval and post-market surveillance of implantable biomaterials. The 2024 revision to the national health ministry's reimbursement policy, which was effective in June, is expected to influence the use of bioglass with a greater incentive for creation of clinical evidence through reimbursement and formal assessment of long-term performance of implants.

Features of the Global Bioglass Market

  • Market Size Estimates: bioglass market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: bioglass market size by type, application, and region in terms of value ($B).
  • Regional Analysis: bioglass market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the bioglass market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioglass market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bioglass market by type (conventional silicate glass, glass ceramics, and borate-based glass), application (dental, orthopedic, grafting biomaterials, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 6 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Bioglass Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Conventional Silicate Glass: Trends and Forecast (2019-2035)
  • 4.4 Glass Ceramics: Trends and Forecast (2019-2035)
  • 4.5 Borate-based Glass: Trends and Forecast (2019-2035)

5. Global Bioglass Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Dental: Trends and Forecast (2019-2035)
  • 5.4 Orthopedic: Trends and Forecast (2019-2035)
  • 5.5 Grafting Biomaterials: Trends and Forecast (2019-2035)
  • 5.6 Others: Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Bioglass Market by Region

7. North American Bioglass Market

  • 7.1 Overview
  • 7.2 North American Bioglass Market by Type
  • 7.3 North American Bioglass Market by Application
  • 7.4 United States Bioglass Market
  • 7.5 Mexican Bioglass Market
  • 7.6 Canadian Bioglass Market

8. European Bioglass Market

  • 8.1 Overview
  • 8.2 European Bioglass Market by Type
  • 8.3 European Bioglass Market by Application
  • 8.4 German Bioglass Market
  • 8.5 French Bioglass Market
  • 8.6 Spanish Bioglass Market
  • 8.7 Italian Bioglass Market
  • 8.8 United Kingdom Bioglass Market

9. APAC Bioglass Market

  • 9.1 Overview
  • 9.2 APAC Bioglass Market by Type
  • 9.3 APAC Bioglass Market by Application
  • 9.4 Japanese Bioglass Market
  • 9.5 Indian Bioglass Market
  • 9.6 Chinese Bioglass Market
  • 9.7 South Korean Bioglass Market
  • 9.8 Indonesian Bioglass Market

10. ROW Bioglass Market

  • 10.1 Overview
  • 10.2 ROW Bioglass Market by Type
  • 10.3 ROW Bioglass Market by Application
  • 10.4 Middle Eastern Bioglass Market
  • 10.5 South American Bioglass Market
  • 10.6 African Bioglass Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Bioglass Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Arthrex
    • Company Overview
    • Bioglass Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Biomet
    • Company Overview
    • Bioglass Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 NORAKER
    • Company Overview
    • Bioglass Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 SCHOTT
    • Company Overview
    • Bioglass Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Stryker
    • Company Overview
    • Bioglass Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 BonAlive Biomaterials
    • Company Overview
    • Bioglass Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 British Glass Manufacturers' Confederation
    • Company Overview
    • Bioglass Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Bioglass Market
  • Figure 2.1: Usage of Bioglass Market
  • Figure 2.2: Classification of the Global Bioglass Market
  • Figure 2.3: Supply Chain of the Global Bioglass Market
  • Figure 3.1: Driver and Challenges of the Bioglass Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Bioglass Market by Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global Bioglass Market ($B) by Type
  • Figure 4.3: Forecast for the Global Bioglass Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Conventional Silicate Glass in the Global Bioglass Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Glass Ceramics in the Global Bioglass Market (2019-2035)
  • Figure 4.6: Trends and Forecast for Borate-based Glass in the Global Bioglass Market (2019-2035)
  • Figure 5.1: Global Bioglass Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global Bioglass Market ($B) by Application
  • Figure 5.3: Forecast for the Global Bioglass Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Dental in the Global Bioglass Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Orthopedic in the Global Bioglass Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Grafting Biomaterials in the Global Bioglass Market (2019-2035)
  • Figure 5.7: Trends and Forecast for Others in the Global Bioglass Market (2019-2035)
  • Figure 6.1: Trends of the Global Bioglass Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global Bioglass Market ($B) by Region (2027-2035)
  • Figure 7.1: North American Bioglass Market by Type in 2019, 2026, and 2035
  • Figure 7.2: Trends of the North American Bioglass Market ($B) by Type (2019-2026)
  • Figure 7.3: Forecast for the North American Bioglass Market ($B) by Type (2027-2035)
  • Figure 7.4: North American Bioglass Market by Application in 2019, 2026, and 2035
  • Figure 7.5: Trends of the North American Bioglass Market ($B) by Application (2019-2026)
  • Figure 7.6: Forecast for the North American Bioglass Market ($B) by Application (2027-2035)
  • Figure 7.7: Trends and Forecast for the United States Bioglass Market ($B) (2019-2035)
  • Figure 7.8: Trends and Forecast for the Mexican Bioglass Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Canadian Bioglass Market ($B) (2019-2035)
  • Figure 8.1: European Bioglass Market by Type in 2019, 2026, and 2035
  • Figure 8.2: Trends of the European Bioglass Market ($B) by Type (2019-2026)
  • Figure 8.3: Forecast for the European Bioglass Market ($B) by Type (2027-2035)
  • Figure 8.4: European Bioglass Market by Application in 2019, 2026, and 2035
  • Figure 8.5: Trends of the European Bioglass Market ($B) by Application (2019-2026)
  • Figure 8.6: Forecast for the European Bioglass Market ($B) by Application (2027-2035)
  • Figure 8.7: Trends and Forecast for the German Bioglass Market ($B) (2019-2035)
  • Figure 8.8: Trends and Forecast for the French Bioglass Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the Spanish Bioglass Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Italian Bioglass Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the United Kingdom Bioglass Market ($B) (2019-2035)
  • Figure 9.1: APAC Bioglass Market by Type in 2019, 2026, and 2035
  • Figure 9.2: Trends of the APAC Bioglass Market ($B) by Type (2019-2026)
  • Figure 9.3: Forecast for the APAC Bioglass Market ($B) by Type (2027-2035)
  • Figure 9.4: APAC Bioglass Market by Application in 2019, 2026, and 2035
  • Figure 9.5: Trends of the APAC Bioglass Market ($B) by Application (2019-2026)
  • Figure 9.6: Forecast for the APAC Bioglass Market ($B) by Application (2027-2035)
  • Figure 9.7: Trends and Forecast for the Japanese Bioglass Market ($B) (2019-2035)
  • Figure 9.8: Trends and Forecast for the Indian Bioglass Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Chinese Bioglass Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the South Korean Bioglass Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the Indonesian Bioglass Market ($B) (2019-2035)
  • Figure 10.1: ROW Bioglass Market by Type in 2019, 2026, and 2035
  • Figure 10.2: Trends of the ROW Bioglass Market ($B) by Type (2019-2026)
  • Figure 10.3: Forecast for the ROW Bioglass Market ($B) by Type (2027-2035)
  • Figure 10.4: ROW Bioglass Market by Application in 2019, 2026, and 2035
  • Figure 10.5: Trends of the ROW Bioglass Market ($B) by Application (2019-2026)
  • Figure 10.6: Forecast for the ROW Bioglass Market ($B) by Application (2027-2035)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Bioglass Market ($B) (2019-2035)
  • Figure 10.8: Trends and Forecast for the South American Bioglass Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the African Bioglass Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Bioglass Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Bioglass Market (2026)
  • Figure 12.1: Growth Opportunities for the Global Bioglass Market by Type
  • Figure 12.2: Growth Opportunities for the Global Bioglass Market by Application
  • Figure 12.3: Growth Opportunities for the Global Bioglass Market by Region
  • Figure 12.4: Emerging Trends in the Global Bioglass Market

List of Tables

  • Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Bioglass Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Bioglass Market by Region
  • Table 1.3: Global Bioglass Market Parameters and Attributes
  • Table 3.1: Trends of the Global Bioglass Market (2019-2026)
  • Table 3.2: Forecast for the Global Bioglass Market (2027-2035)
  • Table 4.1: Attractiveness Analysis for the Global Bioglass Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Bioglass Market (2019-2026)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Bioglass Market (2027-2035)
  • Table 4.4: Trends of Conventional Silicate Glass in the Global Bioglass Market (2019-2026)
  • Table 4.5: Forecast for Conventional Silicate Glass in the Global Bioglass Market (2027-2035)
  • Table 4.6: Trends of Glass Ceramics in the Global Bioglass Market (2019-2026)
  • Table 4.7: Forecast for Glass Ceramics in the Global Bioglass Market (2027-2035)
  • Table 4.8: Trends of Borate-based Glass in the Global Bioglass Market (2019-2026)
  • Table 4.9: Forecast for Borate-based Glass in the Global Bioglass Market (2027-2035)
  • Table 5.1: Attractiveness Analysis for the Global Bioglass Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Bioglass Market (2019-2026)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Bioglass Market (2027-2035)
  • Table 5.4: Trends of Dental in the Global Bioglass Market (2019-2026)
  • Table 5.5: Forecast for Dental in the Global Bioglass Market (2027-2035)
  • Table 5.6: Trends of Orthopedic in the Global Bioglass Market (2019-2026)
  • Table 5.7: Forecast for Orthopedic in the Global Bioglass Market (2027-2035)
  • Table 5.8: Trends of Grafting Biomaterials in the Global Bioglass Market (2019-2026)
  • Table 5.9: Forecast for Grafting Biomaterials in the Global Bioglass Market (2027-2035)
  • Table 5.10: Trends of Others in the Global Bioglass Market (2019-2026)
  • Table 5.11: Forecast for Others in the Global Bioglass Market (2027-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Bioglass Market (2019-2026)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Bioglass Market (2027-2035)
  • Table 7.1: Trends of the North American Bioglass Market (2019-2026)
  • Table 7.2: Forecast for the North American Bioglass Market (2027-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Bioglass Market (2019-2026)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Bioglass Market (2027-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Bioglass Market (2019-2026)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Bioglass Market (2027-2035)
  • Table 7.7: Trends and Forecast for the United States Bioglass Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Bioglass Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Bioglass Market (2019-2035)
  • Table 8.1: Trends of the European Bioglass Market (2019-2026)
  • Table 8.2: Forecast for the European Bioglass Market (2027-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Bioglass Market (2019-2026)
  • Table 8.4: Market Size and CAGR of Various Type in the European Bioglass Market (2027-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Bioglass Market (2019-2026)
  • Table 8.6: Market Size and CAGR of Various Application in the European Bioglass Market (2027-2035)
  • Table 8.7: Trends and Forecast for the German Bioglass Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Bioglass Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Bioglass Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Bioglass Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Bioglass Market (2019-2035)
  • Table 9.1: Trends of the APAC Bioglass Market (2019-2026)
  • Table 9.2: Forecast for the APAC Bioglass Market (2027-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Bioglass Market (2019-2026)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Bioglass Market (2027-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Bioglass Market (2019-2026)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Bioglass Market (2027-2035)
  • Table 9.7: Trends and Forecast for the Japanese Bioglass Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Bioglass Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Bioglass Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Bioglass Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Bioglass Market (2019-2035)
  • Table 10.1: Trends of the ROW Bioglass Market (2019-2026)
  • Table 10.2: Forecast for the ROW Bioglass Market (2027-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Bioglass Market (2019-2026)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Bioglass Market (2027-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Bioglass Market (2019-2026)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Bioglass Market (2027-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Bioglass Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Bioglass Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Bioglass Market (2019-2035)
  • Table 11.1: Product Mapping of Bioglass Suppliers Based on Segments
  • Table 11.2: Operational Integration of Bioglass Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Bioglass Revenue
  • Table 12.1: New Product Launches by Major Bioglass Producers (2019-2026)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Bioglass Market